Metizolam: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 31: | Line 31: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
<gallery> | |||
File:Desmethyletizolam.svg|Metizolam | |||
</gallery> | |||
Latest revision as of 00:59, 20 February 2025
Metizolam (marketed under the brand name Tranzilam) is a thienodiazepine drug which is a benzodiazepine analog. The effects of metizolam include anxiolytic, drowsiness, muscle relaxation, and amnesia which are typical of such drugs.
Pharmacology[edit]
Metizolam has been found to be roughly the same potency as diazepam, but with a slightly longer half-life. It is metabolized in the liver into the active metabolite alpha-hydroxymetizolam.
Medical Uses[edit]
Metizolam is used for the short-term treatment of insomnia, anxiety, and panic disorder. It is also used as a premedication for minor surgical procedures.
Side Effects[edit]
Common side effects of metizolam include drowsiness, dizziness, nausea, and dry mouth. More serious side effects may include respiratory depression, dependence, and withdrawal syndrome.
Interactions[edit]
Metizolam may interact with other medications, including other CNS depressants, alcohol, and grapefruit juice. These interactions can increase the risk of side effects and should be avoided.
Legal Status[edit]
In many countries, metizolam is a controlled substance due to its potential for abuse and dependence.
See Also[edit]
References[edit]
<references />
-
Metizolam
